oxandrolone has been researched along with Abnormalities, Autosome in 2 studies
Oxandrolone: A synthetic hormone with anabolic and androgenic properties.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zeger, MP | 1 |
Shah, K | 1 |
Kowal, K | 1 |
Cutler, GB | 1 |
Kushner, H | 1 |
Ross, JL | 1 |
Rochiccioli, P | 1 |
Battin, J | 1 |
Bertrand, AM | 1 |
Bost, M | 1 |
Cabrol, S | 1 |
le Bouc, Y | 1 |
Chaussain, JL | 1 |
Chatelain, P | 1 |
Colle, M | 1 |
Czernichow, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Androgen, Estrogen, and the Combination of Androgen and Estrogen on Growth Rate and Cognitive Function of Growth Hormone-treated Girls With Turner Syndrome[NCT00029159] | Phase 3 | 200 participants (Actual) | Interventional | 1992-11-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 trials available for oxandrolone and Abnormalities, Autosome
Article | Year |
---|---|
Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
Topics: Adolescent; Adolescent Development; Androgens; Body Height; Bone Density; Child; Child Development; | 2011 |
Final height in Turner syndrome patients treated with growth hormone.
Topics: Age Determination by Skeleton; Anabolic Agents; Body Height; Child; Chromosome Aberrations; Chromoso | 1995 |